Viewing Study NCT06448455



Ignite Creation Date: 2024-06-16 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06448455
Status: RECRUITING
Last Update Posted: 2024-06-10
First Post: 2024-06-03

Brief Title: Observation on the Frailty Status of Lung Cancer Patients
Sponsor: Peking University Third Hospital
Organization: Peking University Third Hospital

Study Overview

Official Title: Observation of Frailty in Lung Cancer Patients and Its Influencing Factors
Status: RECRUITING
Status Verified Date: 2024-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Using the Integrated Conceptual Model of Frailty ICMF and Frailty Framework among Vulnerable Population FFVP as theoretical basis the frailty status of lung cancer patients is described and the physiological psychological and social frailty of lung cancer patients are comprehensively evaluated and analyzed The influencing factors related to frailty are explored in order to provide a basis for effective intervention research on lung cancer patients in the future
Detailed Description: The frailty of lung cancer patients is the result of multiple systems and factors and its pathological and physiological changes include neuroendocrine disorders malnutrition sarcopenia chronic inflammatory reactions etc accompanied by comorbidities and aging and various factors promote the occurrence of frailty Previous studies have found that older age female gender low education level multiple drug use smoking lack of exercise comorbidities falls sleep disorders and anxiety and depression are the influencing factors of frailty in the elderly When many domestic scholars study the frailty characteristics of elderly lung cancer patients they have found that patients with advanced age low BMI divorce or widowhood smoking higher lung cancer staging comorbidities with other diseases multiple medications poor nutrition lower daily living ability long disease course depression and lower red blood cells albumin and hemoglobin are more prone to frailty

In summary lung cancer patients are at risk of frailty with a high incidence and an impact on the occurrence of adverse health outcomes The conclusions drawn from different studies regarding the incidence and measurement of frailty in lung cancer patients vary The frailty of lung cancer patients is influenced by multiple factors not only involving demographic and disease-related factors At present there is limited research both domestically and internationally mainly focusing on the impact of frailty in lung cancer patients on adverse health outcomes There is a lack of research on the current situation and related factors of frailty in lung cancer patients Most studies have explored demographic and disease-related factors in lung cancer patients with little involvement in other variables such as psychological and social factors Given the significant importance of frailty intervention in improving the health status of lung cancer patients it is necessary to comprehensively evaluate the frailty status and related factors of lung cancer patients Therefore this study intends to use the Integrated Conceptual Model of Frailty ICMF and Frailty Framework among Vulnerable Population FFVP as theoretical basis to describe the frailty status of lung cancer patients comprehensively evaluate and analyze the physiological psychological and social frailty of lung cancer patients and explore the influencing factors related to frailty in order to provide a basis for effective intervention research on lung cancer patients in the future

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None